VRD versus VCD as induction therapy before autologous stem cell transplantation in multiple myeloma: a nationwide population-based study

• Jakob Nordberg Nørgaard,
• Kari Lenita Falck Moore,
• Tobias S. Slørdahl,
• Anders Vik,
• Tor Henrik Anderson Tvedt,
• Fredrik Schjesvold

Affiliations

Jakob Nordberg Nørgaard

Oslo Myeloma Center, Department of Hematology, Oslo University Hospital

Kari Lenita Falck Moore

Oslo Myeloma Center, Department of Hematology, Oslo University Hospital

Tobias S. Slørdahl

Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU)

Anders Vik

Department of Hematology, University Hospital of North Norway

Tor Henrik Anderson Tvedt

Department of Hematology, Oslo University Hospital

Fredrik Schjesvold

Oslo Myeloma Center, Department of Hematology, Oslo University Hospital